Huge boost for Cork’s pharma and health tech future as new funding announced

Huge boost for Cork’s pharma and health tech future as new funding announced

UCC and CIT have been awarded investment for the next generation of Health and Life Science graduates.

University College Cork (UCC) and the Cork Institute of Technology (CIT) are among those benefitting from an €8.7m investment in the next generation of Health and Life Science industry graduates.

The funding has been awarded to UCC and CIT, along with nine industry partners who have come together to develop the iEd Hub, which will produce a new generation of graduates and provide a boost for Cork’s pharmaceutical and technological future.

The iEd Hub will allow for the deepening of relationships with local enterprise partners in education, Research and Development as well as new company formations which will benefit the local economy.

Professor Helen Whelton, Head of the College and Medicine at UCC will lead the iEd Hub with Dr Mark Tangney, a senior researcher in the college.
Professor Helen Whelton, Head of the College and Medicine at UCC will lead the iEd Hub with Dr Mark Tangney, a senior researcher in the college.

Pharmaceutical and medical goods currently account for 31 percent of Ireland’s total exports, with Cork as Ireland’s largest Foreign Direct Investment (FDI) cluster in the sector. 

In total, UCC has been awarded €14.4m under the Irish Government’s Human Capital Initiative which is designed to meet the skills required across Ireland’s economy.

Speaking on the funding, Professor John O’Halloran, Interim President at UCC said:

“UCC is Ireland’s leading university for industry engagement and our success in this funding is recognition of our knowledge of the type of graduate and skills that are required across industry sectors.” 

More in this section

Sponsored Content